日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Screening Mammography Utilization among Transgender and Gender Diverse Individuals: Insights from a Large Single Institution Center

跨性别者和性别多元人群乳腺癌筛查利用情况:来自大型单一机构中心的启示

Krishnamurthy, Nithya; Ravetch, Ethan; Karim, Subha; Safer, Joshua D

Zip-Code Level Disadvantage as a Predictor of Metastatic Breast Cancer at Diagnosis and Delayed Treatment Initiation

邮政编码级别的劣势作为诊断时转移性乳腺癌和延迟治疗启动的预测因素

Parmar, Priyanka; Lin, Jessica; Bhimani, Fardeen; Jao, Laura; Sheckley, Michelle; Giron, Andreina; Chen, Yu; Jindani, Rajika; Entenberg, David; Oktay, Maja; Ravetch, Ethan; Gupta, Anjuli; Pastoriza, Jessica; McEvoy, Maureen; Feldman, Sheldon

Fc-optimized CD40 agonistic antibody elicits tertiary lymphoid structure formation and systemic antitumor immunity in metastatic cancer

Fc优化的CD40激动性抗体可诱导转移性癌症中三级淋巴结构形成和全身抗肿瘤免疫。

Juan C Osorio,David A Knorr,Polina Weitzenfeld,Lucas Blanchard,Ning Yao,Maria Baez,Carlo Sevilla,Meghan DiLillo,Jahan Rahman,Ved P Sharma,Jacqueline Bromberg,Michael A Postow,Charlotte Ariyan,Mark E Robson,Jeffrey V Ravetch

Fc-optimized CD40 agonistic antibody elicits tertiary lymphoid structure formation and systemic antitumor immunity in metastatic cancer

Fc优化的CD40激动性抗体可诱导转移性癌症中三级淋巴结构形成和全身抗肿瘤免疫。

Juan C Osorio ,David A Knorr ,Polina Weitzenfeld ,Lucas Blanchard ,Ning Yao ,Maria Baez ,Carlo Sevilla ,Meghan DiLillo ,Jahan Rahman ,Ved P Sharma ,Jacqueline Bromberg ,Michael A Postow ,Charlotte Ariyan ,Mark E Robson ,Jeffrey V Ravetch

Antibody-lectin chimeras for glyco-immune checkpoint blockade

用于糖免疫检查点阻断的抗体-凝集素嵌合体

Stark, Jessica C; Gray, Melissa A; Ibarlucea-Benitez, Itziar; Lustig, Marta; Bond, Annalise; Cho, Brian; Govil, Ishika; Luu, Tran; Priestley, Megan J; Veth, Tim S; Errington, Wesley J; Bruncsics, Bence; Ribi, Mikaela K; Williams, Leo A; Sarkar, Casim A; Wisnovsky, Simon; Riley, Nicholas M; Morrissey, Meghan A; Valerius, Thomas; Ravetch, Jeffrey V; Bertozzi, Carolyn R

Asymmetrically glycosylated IgG1 antibodies are universal and drive human disease.

不对称糖基化的 IgG1 抗体是普遍存在的,并且是人类疾病的驱动因素。

Azzam Tala, Bournazos Stylianos, Gunduz Hasret, Adams Trevor, Flowers Maria W, Niejadlik Emily G, Duong Veasna, Brown Trenton J, Roberts Anne M, Sastre Diego E, Avci Fikri Y, Lam Wilbur A, Cantaert Tineke, Roberts Blaine R, Diamond Betty, Ravetch Jeffrey V, Du Jonathan J, Sundberg Eric J

The mechanistic basis for interprotomer deglycosylation of antibodies by corynebacterial IgG-specific endoglycosidases

棒状杆菌IgG特异性内切糖苷酶介导抗体亚基间去糖基化的机制基础

Diego E Sastre ,Stylianos Bournazos ,Maros Huliciak ,Barbara Ann C Grace ,E Josephine Boder ,Jonathan Du ,Nazneen Sultana ,Tala Azzam ,Trenton J Brown ,Maria W Flowers ,Pete Lollar ,Ting Xu ,Tatiana A Chernova ,Alasdair D Keith ,Meredith Keen ,Abigail Saltzman ,Ana Martinez Gascueña ,Beatriz Trastoy ,Marcelo E Guerin ,Filipp Frank ,Eric A Ortlund ,Jeffrey V Ravetch ,Eric J Sundberg

Fc-optimized anti-CTLA-4 antibodies increase tumor-associated high endothelial venules and sensitize refractory tumors to PD-1 blockade

Fc优化的抗CTLA-4抗体可增加肿瘤相关高内皮静脉的数量,并使难治性肿瘤对PD-1阻断疗法更加敏感。

Lucas Blanchard,Estefania Vina,Jerko Ljubetic,Cécile Meneur,Dorian Tarroux,Maria Baez,Alessandra Marino,Nathalie Ortega,David A Knorr,Jeffrey V Ravetch,Jean-Philippe Girard

Fc-optimized anti-CTLA-4 antibodies increase tumor-associated high endothelial venules and sensitize refractory tumors to PD-1 blockade

Fc优化的抗CTLA-4抗体可增加肿瘤相关高内皮静脉的数量,并使难治性肿瘤对PD-1阻断疗法更加敏感。

Lucas Blanchard ,Estefania Vina ,Jerko Ljubetic ,Cécile Meneur ,Dorian Tarroux ,Maria Baez ,Alessandra Marino ,Nathalie Ortega ,David A Knorr ,Jeffrey V Ravetch ,Jean-Philippe Girard

Clinical characteristics of transgender patients with breast cancer: a single institution experience

跨性别乳腺癌患者的临床特征:单中心经验

Ravetch, Ethan; Krishnamurthy, Nithya; Weltz, Christina; Safer, Joshua D